Literature DB >> 2523252

Kinetic analysis of the in vitro cell-killing action of neocarzinostatin.

S Ozawa1, M Inaba.   

Abstract

The relationship between the drug concentration and exposure time of neocarzinostatin (NCS) for a definite cell-killing effect was kinetically analyzed, taking into consideration its loss in biological activity during incubation. Its cell-killing activity was determined by a colony-forming inhibition assay, which was conducted at room temperature (25 degrees C) for 0.5-30 min exposure and at 37 degrees C for 5 min - 96 h exposure. Drug degradation at both temperatures was also investigated by bioassay. NCS lost its biological activity much faster at 37 degrees C than at 25 degrees C and the rate of loss in activity was higher at the lower initial concentration. Thus, the initial NCS concentrations necessary for 90% cell kill corresponding to each exposure time and a drug degradation constant were applied to a mathematical equation for the cell-killing effect of cell-cycle-phase-nonspecific agents. As a result, the curves for IC90-exposure time relationships predicted from drug degradation constants for 37 degrees C and 25 degrees C were fairly well fitted to the respective experimental data. These results indicate that the cell-killing action of NCS can be expressed by this mathematical equation with scrutiny of drug degradation and is dependent on the concentration-time product (C x T).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523252     DOI: 10.1007/bf00292404

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents.

Authors:  W J Jusko
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

2.  Biological activities of non-protein chromophores of antitumor protein antibiotics: auromycin and neocarzinostatin.

Authors:  H Suzuki; K Miura; Y Kumada; T Takeuchi; N Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1980-05-14       Impact factor: 3.575

3.  Neocarzinostatin chromophore: purification of the major active form and characterization of its spectral and biological properties.

Authors:  M A Napier; B Holmquist; D J Strydom; I H Goldberg
Journal:  Biochemistry       Date:  1981-09-15       Impact factor: 3.162

Review 4.  [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].

Authors:  K Ohtsuki; N Ishida
Journal:  Tanpakushitsu Kakusan Koso       Date:  1981-06

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities.

Authors:  Y Koide; F Ishii; K Hasuda; Y Koyama; K Edo; S Kitamine; F Kitame; N Ishida
Journal:  J Antibiot (Tokyo)       Date:  1980-03       Impact factor: 2.649

7.  The biological effect of a nonprotein component removed from neocarzinostatin (NCS).

Authors:  K Ohtsuki; N Ishida
Journal:  J Antibiot (Tokyo)       Date:  1980-07       Impact factor: 2.649

8.  Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.

Authors:  L S Kappen; I H Goldberg
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

9.  Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

Authors:  S Ozawa; Y Sugiyama; Y Mitsuhashi; T Kobayashi; M Inaba
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.

Authors:  H Suzuki; S Ozawa; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1980-12       Impact factor: 2.649

View more
  1 in total

1.  Investigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical model.

Authors:  Cheng-Ying Chou; Chih-Kang Huang; Kuo-Wei Lu; Tzyy-Leng Horng; Win-Li Lin
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.